Comparison of the Restoration of Hip Biomechanical Parameters by CT Measurement Between the 3 Surgical Techniques: RSA/Minihip/THA - Hip Replacement: 3D Planning
Launched by UNIVERSITY HOSPITAL, LILLE · Feb 15, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to compare different surgical techniques for hip replacement in patients with a condition called coxarthrosis, which is a form of arthritis affecting the hip joint. The study will look at how well these surgeries restore normal hip movement and function by measuring certain parameters before and after the procedures. Participants will undergo a special type of imaging called EOS radiography before their surgery and then again at three months and one year after surgery, along with a CT scan after three months.
To be eligible for this study, participants must be at least 18 years old and scheduled for one of the three types of hip surgeries: total hip replacement, Minihip, or hip resurfacing. They should not have severe arthritis in the other hip, and must be willing to follow the study requirements. Participants will be asked to complete questionnaires and undergo clinical examinations at various points during the study. The trial is currently not recruiting, but it aims to provide valuable insights into how different surgical approaches can affect recovery and hip function.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female
- • Age ≥ 18 years
- • Planned surgery: total hip arthroplasty, Minihip or RSA
- • Absence of osteoarthritis or osteoarthritis ≤ stage 1 (Tönnis classification) of contralateral hip (Radiographic analysis)
- • Patient having given his/her non-opposition to participate in the study
- • Patient with social insurance
- • Patient willing to comply with all study procedures and duration
- Exclusion Criteria:
- * Patient with comorbidity(ies) likely to affect biomechanical parameter measurements or surgical conditions:
- • Anomalies or anatomical changes of the hip, pelvis or lumbar spine (history of fracture, protrusion, scoliosis, history of orthopedic surgery, dysplasia, torsion disorder)
- • Established genetic disease affecting the musculoskeletal system
- • Severe or morbid obesity
- • Neuromuscular pathologies affecting the limb girdles
- • Severe osteoporosis
- • Bone location of primary or metastatic cancer (spine, pelvis or femur) - Inequality of lower limb length \> 2 cm.
- • Minors
- • Protected adults
- • Pregnant or breast-feeding women
- • Administrative reasons: inability to receive informed information, inability to participate in the entire study, lack of social security coverage, refusal to participate.
About University Hospital, Lille
University Hospital Lille is a leading academic medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the hospital leverages its extensive resources, multidisciplinary expertise, and state-of-the-art facilities to facilitate groundbreaking studies across various medical fields. Committed to enhancing therapeutic options and improving patient outcomes, University Hospital Lille collaborates with researchers, healthcare professionals, and industry partners to ensure rigorous scientific standards and ethical practices in all clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported